Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors

PURPOSE: Subsets of pituitary tumors exhibit an aggressive clinical courses and recur despite surgery, radiation, and chemotherapy. Because modulation of the immune response through inhibition of T-cell checkpoints has led to durable clinical responses in multiple malignancies, we explored whether p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Yu, Bi, Wenya Linda, Greenwald, Noah F., Du, Ziming, Agar, Nathalie Y. R., Kaiser, Ursula B., Woodmansee, Whitney W., Reardon, David A., Freeman, Gordon J., Fecci, Peter E., Laws, Edward R., Santagata, Sandro, Dunn, Gavin P., Dunn, Ian F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363530/
https://www.ncbi.nlm.nih.gov/pubmed/27655724
http://dx.doi.org/10.18632/oncotarget.12088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363530/
https://www.ncbi.nlm.nih.gov/pubmed/27655724
http://dx.doi.org/10.18632/oncotarget.12088

Ejemplares similares